|
1
|
Baerwald CG, Burmester GR and Krause A:
Interactions of autonomic nervous, neuroendocrine, and immune
systems in rheumatoid arthritis. Rheum Dis Clin North Am.
26:841–857. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bergquist J, Tarkowski A, Ekman R and
Ewing A: Discovery of endogenous catecholamines in lymphocytes and
evidence for catecholamine regulation of lymphocyte function via an
autocrine loop. Proc Natl Acad Sci USA. 91:12912–12916. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lorton D, Lubahn C and Bellinger DL:
Potential use of drugs that target neural-immune pathways in the
treatment of rheumatoid arthritis and other autoimmune diseases.
Curr Drug Targets Inflamm Allergy. 2:1–30. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Felsner P, Hofer D, Rinner I, Mangge H,
Gruber M, Korsatko W and Schauenstein K: Continuous in vivo
treatment with catecholamines suppresses in vitro reactivity of rat
peripheral blood T-lymphocytes via alpha-mediated mechanisms. J
Neuroimmunol. 37:47–57. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Elenkov IJ, Papanicolaou DA, Wilder RL and
Chrousos GP: Modulatory effects of glucocorticoids and
catecholamines on human interleukin-12 and interleukin-10
production: Clinical implications. Proc Assoc Am Physicians.
108:374–381. 1996.PubMed/NCBI
|
|
6
|
Panina-Bordignon P, Mazzeo D, Lucia PD,
D'Ambrosio D, Lang R, Fabbri L, Self C and Sinigaglia F:
Beta2-agonists prevent Th1 development by selective inhibition of
interleukin 12. J Clin Invest. 100:1513–1519. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hernández FT, Zapater P, De-Madaria E,
Palazón JM, Pascual S, Irurzun J, Such J, Perez-Mateo M and Horga
JF: Functional status of beta-2-adrenoceptor in isolated membranes
of mature erythrocytes from patients with cirrhosis and oesophageal
varices. Vascul Pharmacol. 44:464–468. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brodde OE, Zerkowski HR, Doetsch N,
Motomura S, Khamssi M and Michel MC: Myocardial beta-adrenoceptor
changes in heart failure: Concomitant reduction in beta 1- and beta
2-adrenoceptor function related to the degree of heart failure in
patients with mitral valve disease. J Am Coll Cardiol. 14:323–331.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu XY, Lin SG, Wang XM, Liu Y, Zhang B,
Lin QX, Yang M and Zhou SF: Evidence for coexistence of three
beta-adrenoceptor subtypes in human peripheral lymphocytes. Clin
Pharmacol Ther. 81:654–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu B, Yi Q, Pirskanen R, Matell G, Eng H
and Lefvert AK: Decreased beta2-adrenergic receptor density on
peripheral blood mononuclear cells in myasthenia gravis. J
Autoimmun. 10:401–406. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Levine JD, Goetzl EJ and Basbaum AI:
Contribution of the nervous system to the pathophysiology of
rheumatoid arthritis and other polyarthritides. Rheum Dis Clin
North Am. 13:369–383. 1987.PubMed/NCBI
|
|
12
|
Härle P, Möbius D, Carr DJ, Schölmerich J
and Straub RH: An opposing time-dependent immune-modulating effect
of the sympathetic nervous system conferred by altering the
cytokine profile in the local lymph nodes and spleen of mice with
type II collagen-induced arthritis. Arthritis Rheum. 52:1305–1313.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Härle P, Pongratz G, Albrecht J, Tarner IH
and Straub RH: An early sympathetic nervous system influence
exacerbates collagen-induced arthritis via CD4+CD25+ cells.
Arthritis Rheum. 58:2347–2355. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Malfait AM, Malik AS, Marinova-Mutafchieva
L, Butler DM, Maini RN and Feldmann M: The beta2-adrenergic agonist
salbutamol is a potent suppressor of established collagen-induced
arthritis: Mechanisms of action. J Immunol. 162:6278–6283.
1999.PubMed/NCBI
|
|
15
|
Lorton D, Bellinger DL, Schaller JA,
Shewmaker E, Osredkar T and Lubahn C: Altered sympathetic-to-immune
cell signaling via β2-adrenergic receptors in adjuvant
arthritis. Clin Dev Immunol. 2013:7643952013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Neuhuber WL and Tiegs G: Innervation of
immune cells: Evidence for neuroimmunomodulation in the liver. Anat
Rec A Discov Mol Cell Evol Biol. 280:884–892. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tiegs G, Bang R and Neuhuber WL:
Requirement of peptidergic sensory innervation for disease activity
in murine models of immune hepatitis and protection by
beta-adrenergic stimulation. J Neuroimmunol. 96:131–143. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grässel SG: The role of peripheral nerve
fibers and their neurotransmitters in cartilage and bone physiology
and pathophysiology. Arthritis Res Ther. 16:4852014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eitner A, Pester J, Nietzsche S, Hofmann
GO and Schaible HG: The innervation of synovium of human
osteoarthritic joints in comparison with normal rat and sheep
synovium. Osteoarthritis Cartilage. 21:1383–1391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Najafipour H and Niazmand S: Alteration in
alpha- and beta- adrenoceptor profile of rabbit-knee-joint blood
vessels due to chronic inflammation. Pflugers Arch. 453:23–32.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Beckmann J, Knödl M, Bauser E, Tingart M,
Grifka J and Straub RH: Loss of sympathetic nerve fibers in vital
intertrochanteric bone cylinders lateral to osteonecrosis of the
femoral head. Joint Bone Spine. 80:188–194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fernandes JC, Martel-Pelletier J and
Pelletier JP: The role of cytokines in osteoarthritis
pathophysiology. Biorheology. 39:237–246. 2002.PubMed/NCBI
|
|
23
|
Malemud CJ: Anticytokine therapy for
osteoarthritis: Evidence to date. Drugs Aging. 27:95–115. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
D'Amico G and Luca A: Natural history.
Clinical-haemodynamic correlations. Prediction of the risk of
bleeding. Baillieres Clin Gastroenterol. 11:243–256. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sanders VM: The beta2-adrenergic receptor
on T and B lymphocytes: Do we understand it yet? Brain Behav Immun.
26:195–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Biecker E: Portal hypertension and
gastrointestinal bleeding: Diagnosis, prevention and management.
World J Gastroenterol. 19:5035–5050. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pateron D, Tazi KA, Sogni P, Heller J,
Chagneau C, Poirel O, Philippe M, Moreau R and Lebrec D: Role of
aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation
of portal hypertension. Gastroenterology. 119:196–200. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tazi KA, Barrière E, Moreau R, Heller J,
Sogni P, Pateron D, Poirel O and Lebrec D: Role of shear stress in
aortic eNOS up-regulation in rats with biliary cirrhosis.
Gastroenterology. 122:1869–1877. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Karadsheh Z and Allison H: Primary
prevention of variceal bleeding: Pharmacological therapy versus
endoscopic banding. N Am J Med Sci. 5:573–579. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lemaitre RN, Heckbert SR, Sotoodehnia N,
Bis JC, Smith NL, Marciante KD, Hindorff LA, Lange LA, Lumley TS,
Rice KM, et al: beta1- and beta2-adrenergic receptor gene
variation, beta-blocker use and risk of myocardial infarction and
stroke. Am J Hypertens. 21:290–296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Heckbert SR, Hindorff LA, Edwards KL,
Psaty BM, Lumley T, Siscovick DS, Tang Z, Durda JP, Kronmal RA and
Tracy RP: Beta2-adrenergic receptor polymorphisms and risk of
incident cardiovascular events in the elderly. Circulation.
107:2021–2024. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sotoodehnia N, Siscovick DS, Vatta M,
Psaty BM, Tracy RP, Towbin JA, Lemaitre RN, Rea TD, Durda JP, Chang
JM, et al: Beta2-adrenergic receptor genetic variants and risk of
sudden cardiac death. Circulation. 113:1842–1848. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stanzione R, Di Angelantonio E,
Evangelista A, Barbato D, Marchitti S, Zanda B, Pirisi A, Quarta G,
Volpe M and Rubattu S: Beta2-adrenergic receptor gene polymorphisms
and risk of ischemic stroke. Am J Hypertens. 20:657–662. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lanfear DE, Jones PG, Marsh S, Cresci S,
McLeod HL and Spertus JA: Beta2-adrenergic receptor genotype and
survival among patients receiving beta-blocker therapy after an
acute coronary syndrome. JAMA. 294:1526–1533. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tan S, Hall IP, Dewar J, Dow E and
Lipworth B: Association between beta 2-adrenoceptor polymorphism
and susceptibility to bronchodilator desensitisation in moderately
severe stable asthmatics. Lancet. 350:995–999. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gianfagna F, Cugino D, Ahrens W, Bailey
ME, Bammann K, Herrmann D, Koni AC, Kourides Y, Marild S, Molnár D,
et al: Understanding the links among neuromedin U gene,
beta2-adrenoceptor gene and bone health: An observational study in
European children. PLoS One. 8:e706322013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Malysheva O, Pierer M, Wagner U, Wahle M,
Wagner U and Baerwald CG: Association between beta2 adrenergic
receptor polymorphisms and rheumatoid arthritis in conjunction with
human leukocyte antigen (HLA)-DRB1 shared epitope. Ann Rheum Dis.
67:1759–1764. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu B, Arlehag L, Rantapää-Dahlquist SB and
Lefvert AK: Beta2-adrenergic receptor gene single-nucleotide
polymorphisms are associated with rheumatoid arthritis in northern
Sweden. Scand J Rheumatol. 33:395–398. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kushnir VM, Cassell B, Gyawali CP,
Newberry RD, Kibe P, Nix BD, Sabzpoushan A, Kanuri ND and Sayuk GS:
Genetic variation in the beta-2 adrenergic receptor (ADRB2)
predicts functional gastrointestinal diagnoses and poorer
health-related quality of life. Aliment Pharmacol Ther. 38:313–323.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kellgren JH and Lawrence JS: Radiological
assessment of osteo-arthrosis. Ann Rheum Dis. 16:494–502. 1957.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bosch J, Abraldes JG, Albillos A, Aracil
C, Bañares R, Berzigotti A, Calleja JL, de la Peña J, Escorsell A,
García-Pagán JC, et al: Portal hypertension: Recommendations for
evaluation and treatment: Consensus document sponsored by the
Spanish association for the study of the liver (AEEH) and the
biomedical research network center for liver and digestive diseases
(CIBERehd). Gastroenterol Hepatol. 35:421–450. 2012.(In Spanish).
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sondergaard SB, Knudsen JH and Christensen
NJ: Regulation of cAMP in a lymphocyte preparation isolated from
peripheral venous blood in human subjects: The significance of
residual thrombocytes, noradrenaline and prostaglandins. Clin Sci
(Lond). 95:377–383. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Drysdale CM, McGraw DW, Stack CB, Stephens
JC, Judson RS, Nandabalan K, Arnold K, Ruano G and Liggett SB:
Complex promoter and coding region beta 2-adrenergic receptor
haplotypes alter receptor expression and predict in vivo
responsiveness. Proc Natl Acad Sci USA. 97:10483–10488. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Belfer I, Buzas B, Hipp H, Phillips G,
Taubman J, Lorincz I, Evans C, Lipsky RH, Enoch MA, Max MB and
Goldman D: Haplotype-based analysis of alpha 2A, 2B, and 2C
adrenergic receptor genes captures information on common functional
loci at each gene. J Hum Genet. 50:12–20. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Campello L, Esteve-Rudd J, Bru-Martinez R,
Herrero MT, Fernández-Villalba E, Cuenca N and Martín-Nieto J:
Alterations in energy metabolism, neuroprotection and visual signal
transduction in the retina of Parkinsonian, MPTP-treated monkeys.
PLoS One. 8:e744392013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Garcia-Tsao G, Sanyal AJ, Grace ND and
Carey W: Practice Guidelines Committee of the American Association
for the Study of Liver Diseases; Practice Parameters Committee of
the American College of Gastroenterology: Prevention and management
of gastroesophageal varices and variceal hemorrhage in cirrhosis.
Hepatology. 46:922–938. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jeanningros R, Mazzola P, Azorin JM,
Samuelian-Massa C and Tissot R: Beta-adrenoceptor density of intact
mononuclear leukocytes in subgroups of depressive disorders. Biol
Psychiatry. 29:789–798. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Maekawa K, Twe C, Lotaif A, Chiappelli F
and Clark GT: Function of beta-adrenergic receptors on mononuclear
cells in female patients with fibromyalgia. J Rheumatol.
30:364–368. 2003.PubMed/NCBI
|
|
49
|
Leineweber K, Rohe P, Beilfuss A, Wolf C,
Sporkmann H, Bruck H, Jakob HG, Heusch G, Philipp T and Brodde OE:
G-protein-coupled receptor kinase activity in human heart failure:
Effects of beta-adrenoceptor blockade. Cardiovasc Res. 66:512–519.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Scarpace PJ, Tumer N and Mader SL:
Beta-adrenergic function in aging. Basic mechanisms and clinical
implications. Drugs Aging. 1:116–129. 1991.PubMed/NCBI
|
|
51
|
Krause A, Henrich A, Beckh KH, Von Wichert
P and Baerwald C: Correlation between density of beta 2-adrenergic
receptors on peripheral blood mononuclear cells and serum levels of
soluble interleukin-2 receptors in patients with chronic
inflammatory diseases. Eur J Clin Invest. 22 Suppl 1:S47–S51.
1992.
|
|
52
|
Baerwald C, Graefe C, Muhl C, Von Wichert
P and Krause A: Beta 2-adrenergic receptors on peripheral blood
mononuclear cells in patients with rheumatic diseases. Eur J Clin
Invest. 22 Suppl 1:S42–S46. 1992.
|
|
53
|
Wahle M, Kölker S, Krause A, Burmester GR
and Baerwald CG: Impaired catecholaminergic signalling of B
lymphocytes in patients with chronic rheumatic diseases. Ann Rheum
Dis. 60:505–510. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Maekawa K, Kuboki T, Inoue E,
Inoue-Minakuchi M, Suzuki K, Yatani H and Clark GT: Function of
beta 2-adrenergic receptors in chronic localized myalgia. J Orofac
Pain. 17:140–144. 2003.PubMed/NCBI
|
|
55
|
Maekawa K, Clark GT and Kuboki T:
Intramuscular hypoperfusion, adrenergic receptors, and chronic
muscle pain. J Pain. 3:251–260. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lefkowitz RJ, Caron MG and Stiles GL:
Mechanisms of membrane-receptor regulation. Biochemical,
physiological, and clinical insights derived from studies of the
adrenergic receptors. N Engl J Med. 310:1570–1579. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
de Galan BE, Rietjens SJ, Tack CJ, van der
Werf SP, Sweep CG, Lenders JW and Smits P: Antecedent adrenaline
attenuates the responsiveness to but not the release of
counterregulatory hormones during subsequent hypoglycemia. J Clin
Endocrinol Metab. 88:5462–5467. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Baerwald CG, Laufenberg M, Specht T, von
Wichert P, Burmester GR and Krause A: Impaired sympathetic
influence on the immune response in patients with rheumatoid
arthritis due to lymphocyte subset-specific modulation of beta
2-adrenergic receptors. Br J Rheumatol. 36:1262–1269. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ader R, Cohen N and Felten D:
Psychoneuroimmunology: Interactions between the nervous system and
the immune system. Lancet. 345:99–103. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Capellino S, Cosentino M, Wolff C, Schmidt
M, Grifka J and Straub RH: Catecholamine-producing cells in the
synovial tissue during arthritis: Modulation of sympathetic
neurotransmitters as new therapeutic target. Ann Rheum Dis.
69:1853–1860. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Straub RH, Grum F, Strauch U, Capellino S,
Bataille F, Bleich A, Falk W, Schölmerich J and Obermeier F:
Anti-inflammatory role of sympathetic nerves in chronic intestinal
inflammation. Gut. 57:911–921. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Brodde OE, Bruck H and Leineweber K:
Cardiac adrenoceptors: Physiological and pathophysiological
relevance. J Pharmacol Sci. 100:323–337. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kirstein SL and Insel PA: Autonomic
nervous system pharmacogenomics: A progress report. Pharmacol Rev.
56:31–52. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Diatchenko L, Anderson AD, Slade GD,
Fillingim RB, Shabalina SA, Higgins TJ, Sama S, Belfer I, Goldman
D, Max MB, et al: Three major haplotypes of the beta2 adrenergic
receptor define psychological profile, blood pressure, and the risk
for development of a common musculoskeletal pain disorder. Am J Med
Genet B Neuropsychiatr Genet. 141B:449–462. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Small KM, McGraw DW and Liggett SB:
Pharmacology and physiology of human adrenergic receptor
polymorphisms. Annu Rev Pharmacol Toxicol. 43:381–411. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zuurhout MJ, Vijverberg SJ, Raaijmakers
JA, Koenderman L, Postma DS, Koppelman GH and Maitland-van der Zee
AH: Arg16 ADRB2 genotype increases the risk of asthma exacerbation
in children with a reported use of long-acting β2-agonists: Results
of the PACMAN cohort. Pharmacogenomics. 14:1965–1971. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Bengtsson K, Orho-Melander M, Melander O,
Lindblad U, Ranstam J, Råstam L and Groop L: Beta(2)-adrenergic
receptor gene variation and hypertension in subjects with type 2
diabetes. Hypertension. 37:1303–1308. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Martinez FD, Graves PE, Baldini M, Solomon
S and Erickson R: Association between genetic polymorphisms of the
beta2-adrenoceptor and response to albuterol in children with and
without a history of wheezing. J Clin Invest. 100:3184–3188. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Gjesing AP, Andersen G, Burgdorf KS,
Borch-Johnsen K, Jørgensen T, Hansen T and Pedersen O: Studies of
the associations between functional beta2-adrenergic receptor
variants and obesity, hypertension and type 2 diabetes in 7,808
white subjects. Diabetologia. 50:563–568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Qing F, Rahman SU, Hayes MJ, Rhodes CG,
Ind PW, Jones T and Hughes JM: Effect of long-term beta2-agonist
dosing on human cardiac beta-adrenoceptor expression in vivo:
Comparison with changes in lung and mononuclear leukocyte
beta-receptors. J Nucl Cardiol. 4:532–538. 1997. View Article : Google Scholar : PubMed/NCBI
|
